際際滷

際際滷Share a Scribd company logo
Staphylococci
 Facultative, non-sporulating, non-motile, Gram positive
cocci
 Cell Division  3 planes
 Daughter cells dont fully separate  form clusters
 Greek nouns
 Staphyle   a bunch of grapes
 Coccus  grain or berry
Disease Manifestations due
to Staphylococcus aureus
 Skin and soft tissue
infections
 Impetigo

 Osteomyelitis

 Endocarditis
 Septic phlebitis
 Catheter infections

 Toxic shock syndrome
 Septicemia
Disease Manifestations due
to Staphylococcus aureus
 Skin and soft tissue
infections
 Impetigo
 Cellulite
 Osteomyelitis
 Pneumonia
 Endocarditis
 Septic phlebitis
 Catheter infections
 Surgical site infections
 Toxic shock syndrome
 Septicemia
 Septic arthritis
Staphylococci
27 species  Three Important Species
 Staphylococcus aureus
 Important human pathogen
 Staphylococcus epidermidis
 Normal skin flora, disease under special circumstances
 Staphylococcus saprophyticus
 UTIs in young females
S. aureus - Epidemiology
 Reservoir  Humans
 Asymptomatic Carriage Sites:




 Skin Colonization - Brief, Repeated
 Transmission -
S. aureus - Epidemiology
 Reservoir  Humans
 Asymptomatic Carriage Sites:
 Nares
 Rectum
 Perineum
 Pharynx
 Skin Colonization - Brief, Repeated
 Transmission - Person to Person
S. aureus Carriage Rates
Population Carriage Rate (%)
General Population 25
Hemodialysis 75
Diabetic on insulin 50
Patients receiving 50
allergy shots
Intravenous Drug Users 40
Staphylococcal Infections - Risk Factors
 Skin Disease
 Increased colonization
 Trauma
 Expose binding sites
 Viral Respiratory Tract
Infection (Influenza)
 Expose binding sites
 Decreased clearance
 Foreign Body
 Liver disease
 Neoplasia
 Diabetes
 Renal Failure
 Leukocyte &
Immunoglobulin Defects
 Elevated Serum IgE
Levels
 Narcotics Addiction
 Broad Spectrum Antibiotic
Therapy
In general  Healthy people dont get serious Staph infections
Patterns of Disease - S. aureus
1) Invasion with Tissue Destruction
2) Toxin Mediated
Patterns of Disease - S. aureus
1) Invasion with Tissue Destruction
2) Toxin Mediated
 Toxic Shock Syndrome
 Scalded Skin Syndrome
 Staphylococcal Food Poisoning
Anterior Nares
Skin Trauma Localized
Colonization Infection
Bacteremia
Metastatic
Foci
Lungs
Endocarditis Liver/Spleen
CNS
Kidneys
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Folliculitis
 Starts as
infection of hair
follicle 
Folliculitis
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
 A 22-month-old boy with a
staphylococcal folliculitis on the buttocks.
The lesions have been excoriated. Diaper
occlusion may have been related to onset
of the rash.
Furuncle
 Often starts as infection of
hair follicle  Folliculitis
 Firm, tender red nodule 
Painful
 Fluctuant with time  Drain
spontaneously
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Furuncles (boil)
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Carbuncle
Larger than furuncle
 Extends into
subcutaneous fat
 Interconnected
 Firm, inelastic skin
Ofooni1_04_Staph.PPT
carbuncle
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Impetigo
 The most common skin infection in
children.
 Causative agent is carried in the nasal area.
 Bacteria invade the superficial skin.
Impetigo
 Superficial infection of skin
 Usually
 S. aureus
 Streptococcus pyogenes
 Children
 Hot Weather
 Minor Trauma
 Initially  vesicles
Impetigo
 Later: Crusted with
yellow  dark brown
material
Impetigo - crusty
Impetigo
Impetigo
Interventions
Good general hygiene
Wash gently with soap and water
Topical antibiotic therapy
Wash hands
Systemic antibiotics only if severe
and does not respond to topical.
(keflex po)
Ofooni1_04_Staph.PPT
Erysipelas
 Strep pyogenes or S.
aureus
 Sharp, raised borders
Erysipelas
Streptococcal Skin Infections
Ofooni1_04_Staph.PPT
Cellulitis
 A full-thickness skin infection
involving dermis and underlying
connective tissue.
 Any part of the body can be
affected.
 Cellulitis around the eyes is usually
an extension of a sinus infection or
otitis media.
Cellulitis
 Acute, spreading
Infection
 Prior trauma to skin
 Warm and
erethematous
Assessment
 History and physical exam
 WBC count
 Blood culture
 Culturing organism from lesion
aspiration.
 CT scan with peri-orbital cellulitis
Clinical Manifestations
 Characteristic reddened or lilac-
colored, swollen skin that pits when
pressed with finger.
 Borders are indistinct.
 Warm to touch.
 Superficial blistering.
Cellulitis
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Periorbital swelling and Fever after dental abscess
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Imaging Air, edema and collection in orbital
cavity
More than 遜 of orbit is anterior to orbital cavity
(proptosis)
Bilateral Ethmoid
sinusitis
Bilateral Maxillary
sinusitis
Bilateral Ethmoidal
sinusitis
Soft tissue swelling and
edema
Bilateral Maxillary
Bilateral Ethmoidal
sinusitis
Soft tissue swelling ,
edema & collection
intraorbital cavity
Congested Nasal
conchea
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Interventions
 Hospitalization if large area involved
or facial cellulitis.
 IV antibiotics.
 Pain management.
 Warm moist packs to area if ordered.
 Assess for spread
 If peri-orbital test for ocular
movement and vision acuity
Ofooni1_04_Staph.PPT
Anatomy of the Eye
sty
Epiphysis
Marrow
Cartilage
Cortex
Epiphyseal plate
Capillary loop
Micro-abscess
Cortex
Periosteum
Marrow
Bone trabeculae
Metaphysis
Pyogenic osteomyelitis -pathogenesis
Cortex
Abscess
Periosteal reactive bone
Bone resorption: osteoclast
Organisation: fibrosis
Trabeculae
New reactive bone: osteoblasts
Pyogenic osteomyelitis -pathogenesis
Expansion of abscess
Periosteal elevation
Shearing of arteries
Subperiosteal
abscess
Reactive bone
Ischemia = osteonecrosis (sequestrum)
Pyogenic osteomyelitis -pathogenesis
Pus in joint
Extension into soft tissue
Draining sinus
Skin
Cortical necrosis =
sequestrum
Reactive bone surround
sequestrum: involucrum
Continuous resorption
Continuous new bone
and fibrosis of marrow
sequestrum
Pyogenic osteomyelitis -pathogenesis
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Ofooni1_04_Staph.PPT
Mitral Valve Endocarditis
Endocardits
Patterns of Disease - S. aureus
1) Invasion with Tissue Destruction
2) Toxin Mediated
 Toxic Shock Syndrome
 Scalded Skin Syndrome
 Staphylococcal Food Poisoning
TOXIC SHOCK SYNDROME
 Acute Febrile Illness
 Subsequent Development of Hypotension
and Shock.
 Noted association with S. aureus phage
group I
 Named the illness "Toxic Shock Syndrome
TOXIC SHOCK SYNDROME
1990 - More than 3,300 cases have been
reported
 95% in women
 90% occurred during menstruation in
women who were using tampons
1989 - 61 cases of TSS reported
Toxic Shock Syndrome -
Epidemiology
1. Menstrual
 Colonization of the Vagina and Cervix
with TSST-1 producing strains of S.
aureus
 Tampon Associated
 Risk proportional to the absorbancy of Tampon
 Not tampon associated
Toxic Shock Syndrome -
Epidemiology
2. Non-menstrual
 Post-surgical
 Influenza associated
 Contraceptive device associated
 Diaphragm
 Sponge
 Postpartum
Pyrogenic Toxin
 Family of Proteins secreted by
 S. aureus
 Strep pyogenes
 Include
 TSST-1
 Staphylococcal Enterotoxins A, B,C
 Pyrogenic Exotoxin A & B
 Streptococcal Scarlet Fever Toxins A, B,C
Toxic Shock Syndrome
- Clinical Manifestations
1. High Fever (>39.9oC)
2. Scarlatiniform Eruption
3. Hypotension and Shock
4. Desquamation during
convalescence
Staphylococcal toxic shock
syndrome
Toxic shock syndrome (TSS)
Toxic shock syndrome toxin
(TSST-1)
Super antigen
Tampon or infected wound, TSST-
1 enters blood stream and cause
fever, rash, exfoliation of skin and
shock (death rate 3%)
Manifestations of Specific Organ
Involvement
 Mucous Membranes: hyperemia
 Gastrointestinal Tract: vomiting and diarrhea
 Muscle: severe myalgias
 Central Nervous System: disorientation
 Kidney: azotemia, pyuria urinary tract infection
 Liver: elevation of serum bilirubin and SGOT
 Blood: Thrombocytopenia
Toxic Shock Syndrome -
Diagnosis
 Isolation of toxin producing S. aureus
from a patient with a compatible
clinical illness.
Toxic Shock Syndrome -
Treatment
1) Treatment of Hypotension and Shock
 Vigorous Fluid Replacement
2) Attention to the Site of S. aureus Colonization
 Removal of Tampons
 Drainage of Staphylococcal Abscess
3) Anti-Staphylococcal Antibiotic Therapy
STAPHYLOCOCCAL SCALDED SKIN SYNDROME
 A Disease of Infants
 Localized Infection with Diffuse Skin Rash
 S. aureus (Phage group II) recovered from:
 Nose
 Pustules
 Eye
 Umbilicus
 Exfoliative Toxin
 Two Serologically and Biologically Distinct Proteins
 Exfoliatin A
 Exfoliatin B
 Inter-Epithelial Splitting of Stratum Granulosum Layer
Staphylococcal Scalded Skin Syndrome -
Clinical Features
 Starts Abruptly
 Perioral erythema
 Sunburn like, tender rash 
spreads over entire body
 Bullae Appear Rapidly
 Nikolsky sign
 Flaccid bullae slough off 
Denuded areas
Staphylococcal Scalded Skin Syndrome -
Clinical Features
 Exfoliated Areas Eventually Dry
 Flaky desquamation lasting 3-5
days
 Within 10 days After Onset
Complete Recovery
 New epidermis has replaced the
denuded areas
Scalded skin syndrome  toxin
Ofooni1_04_Staph.PPT
Staphylococcal scalded skin syndrom (SSSS)
Exfoliative toxin (epidermolytic toxin)
Bullous exfoliative dermatitis
Staphylococcal Food Poisoning
 20% of Outbreaks of Acute Food
Poisoning
 Toxigenic Strain of S. aureus growing in
contaminated food
 Produces Enterotoxin B (Heat Stable)
 Person to Person Transmission
 Responsible organism usually isolated from person
involved meal preparation
Staphylococcal Food Poisoning
 Commonly implicated foods
 Custard filled bakery good
 Canned food
 Potato salad
 Ice cream
 Food appears normal in
appearance, odor and taste
Staphylococcal Food Poisoning -
Clinical Features
 Incubation period 2-6 hours
 Enterotoxin stimulates intestinal
peristalsis and CNS
 Abrupt onset:
 Salivation
 Nausea and vomiting
 Abdominal cramps
 Watery diarrhea
 Afebrile
 Self limited, symptoms disappear in 8 hours
Ofooni1_04_Staph.PPT
S. aureus
Evolution of Drug Resistance in S. aureus
Methicillin
[1970s]
Methicillin-
resistant
S. aureus (MRSA)
S. aureus
Penicillin
[1950s]
Penicillin-resistant
Vancomycin-resistant
enterococci (VRE)
Vancomycin
[1990s]
[1997]
Vancomycin
intermediate-
resistant
S. aureus
(VISA)
[ 2002 ]
Vancomycin-
resistant
S. aureus
Bone5:
7%13%
Vancomycin Penetration
Sternal Bone1:
57%
Heart Valve4:
12%
CNS:
<10%
Fat4:
14%
Muscle4:
9%
Epithelial
lining fluid3:
18%
Lung tissue2:
17%24%
1. Massias L et al. Antimicrob Agents Chemother. 1992;36:2539-2541; 2. Cruciani M et al. J Antimicrob
Chemother. 1996;38:865-869. 3. Lamer C et al. Antimicrob Agents Chemother. 1993;37:281-286;
MRSA in Europe.
In England and Wales, from
January to December 1999
methicillin resistance was
37% of the S.aureus reports.
Except Scandinavia and
Netherlands most countries
have high rates of MRSA.
0
10
20
30
40
50
60
1
9
7
5
8
7
8
8
8
9
9
0
9
1
9
2
9
3
9
4
9
5
9
6
9
7
9
8
9
9
2
0
0
0
2
0
0
2
Resistant
isolates
(%)
CDC. MMWR. 1997;46:624-628, 635. (1975 data); Lowy FD. N Engl J Med. 1998;339:520-532.
Progression of Methicillin Resistant
S aureus  United States 13%
居件縁
居居鰹
Staphylococcus aureus
(N0=224)
CD
ER
LZD
PG
TS
RP
OX
CIP
C
KF
AK
T
VA
QD
GM
FU
R 53
(24)
80
(36)
4
(2)
215
(96)
92
(41)
20
(9)
78
(35)
72
(32)
5
(2)
71
(32)
70
(31)
102
(45)
0
(0)
0
(0)
72
(32)
8
(4)
S 170
(76)
130
(58)
220
(98)
9
(4)
131
(58)
203
(90)
146
(65)
148
(66)
218
(97)
151
(67)
150
(68)
122
(55)
224
(100)
224
(100)
152
(68)
216
(96)
IR 1
(0.5)
14
(6)
0
(0)
0
(0)
1
(.5)
1
(.5)
0
(0)
4
(2)
1
(.5)
2
(1)
3
(1)
0
(0)
0
(0)
0
(0)
0
(0)
0
(0)
CD=Clindamycin, ER=erythromycin, LZD=linezolid, PG=PenicillinG, TS=Co-trimoxazol, RP=Rifampin,
OX=Oxacillin, CIP=Ciprofloxacin, C=Chloramphenicol, KF=Cephalothin, AK=Amikacin, T=Tetracycline,
VA=Vancomycin, QD=Quinupristin-dalfopristin, GM=Gentamycin, FU=Fusidic acid
Reservoir for the Spread of
Antibiotic Resistant Pathogens
clinical
infections
colonized
(asymptomatic)
Standard Precautions for Health
Care workers include:
 Hand hygiene / handwashing- before and after
patient contact and after touching contaminated
items
 Gloving - when touching blood, body fluids,
secretions, excretions,and contaminated items
 Masking  if aerosol of infectious material
expected
 Gowning
 Appropriate handling of laundry
Most common mode of
transmission of pathogens is via
hands!
So Why All the Fuss About
Hand Hygiene?
The Inanimate Environment Can
Facilitate Transmission
~ Contaminated surfaces increase cross-transmission ~
Abstract: The Risk of Hand and Glove Contamination after Contact with a
VRE (+) Patient Environment. Hayden M, ICAAC, 2001, Chicago, IL.
X represents VRE culture positive sites
Staphylococcus epidermidis
 Normal Flora
 Virtually all humans carry S. epidermidis on the skin
and in and around body orifices
 Hospital Acquired Infection
 Contamination by S. epidermidis carried by the patient
 most important event in infections associated
with foreign bodies
Staphylococcus epidermidis
 opportunistic infection
- less common than S.aureus
 nosomial infections
- shunts, catheters
 artificial heart valves/joints
S. epidermidis - Patterns of Infection
 Nosocomial Bacteremia -most common cause
 Endocarditis
A. Native Valve
 Uncommon- 5% of cases
B. Prosthetic Valve
 Single most common cause (40% of cases)
 Probably caused by inoculation at the time
of surgery
 Indolent course
S. epidermidis - Patterns of Infection
 Intravenous Catheters
-Single most common cause (50-75% of cases)
 Cerebrospinal Fluid Shunts
 Peritoneal Dialysis Catheter
 Vascular Grafts
 Prosthetic Joints
S. epidermidis Infection -
Treatment
1. Antimicrobial Therapy
 Usually resistant to multiple antibiotics
 Beta lactams
 Erythromycin, Clindamycin, Tetracycline
 Require therapy with Vancomycin
2. Removal of Foreign Body
Staphylococcus saprophyticus
 Colonizes the genitourinary mucosa of some young
women
 Causes both upper and lower urinary tract disease
 95% of cases are in females 16-35 years old
 Responsible for 20% of the UTI's in this age group
 Second only to E. coli
 Pathogen of young, sexually active females
 70% sexual intercourse within 24 hours preceding onset of
symptoms

More Related Content

Similar to Ofooni1_04_Staph.PPT (20)

Microbiology lec5
Microbiology   lec5Microbiology   lec5
Microbiology lec5
MBBS IMS MSU
Skin and wound infection
Skin and wound infectionSkin and wound infection
Skin and wound infection
Saeed Bajafar
Skin disease ppt for nursing student
Skin disease ppt for nursing studentSkin disease ppt for nursing student
Skin disease ppt for nursing student
Patel Dharmendra
Skin and Soft Tissue Infections
Skin and Soft Tissue Infections Skin and Soft Tissue Infections
Skin and Soft Tissue Infections
Nireshan Naidoo
L1-SKIN-SOFT-TISSUE-MODEFIED.ppt
L1-SKIN-SOFT-TISSUE-MODEFIED.pptL1-SKIN-SOFT-TISSUE-MODEFIED.ppt
L1-SKIN-SOFT-TISSUE-MODEFIED.ppt
AISHWARYATD2
BACTERIAL120INFECTIONS.pptx
BACTERIAL120INFECTIONS.pptxBACTERIAL120INFECTIONS.pptx
BACTERIAL120INFECTIONS.pptx
GhazalaRizwan3
conj diseases main.pptx
conj diseases main.pptxconj diseases main.pptx
conj diseases main.pptx
Harmanjot Singh
Dr hussein, bacterial infec of the skin
Dr hussein, bacterial infec of the skinDr hussein, bacterial infec of the skin
Dr hussein, bacterial infec of the skin
MEEQAT HOSPITAL
Skin conditions of surgical Importance.pptx
Skin conditions of surgical Importance.pptxSkin conditions of surgical Importance.pptx
Skin conditions of surgical Importance.pptx
DakaneMaalim
Bacterial infection of the skin
Bacterial infection of the skin Bacterial infection of the skin
Bacterial infection of the skin
MEEQAT HOSPITAL
Staphylococcus aureus
Staphylococcus aureusStaphylococcus aureus
Staphylococcus aureus
IRFAN UL HAQ
Pathology of Skin - Common Disorders
Pathology of Skin - Common DisordersPathology of Skin - Common Disorders
Pathology of Skin - Common Disorders
Shashidhar Venkatesh Murthy
Staphylococcus aureus
Staphylococcus aureusStaphylococcus aureus
Staphylococcus aureus
Athira B
Skin and soft tissue infections
Skin and soft tissue infectionsSkin and soft tissue infections
Skin and soft tissue infections
AMIT KUMAR
Microbiology 2009
Microbiology 2009Microbiology 2009
Microbiology 2009
kmwall
Skin and soft tissue infections for mbbs student.pptx
Skin and soft tissue infections for mbbs student.pptxSkin and soft tissue infections for mbbs student.pptx
Skin and soft tissue infections for mbbs student.pptx
sheetalbadsar19
Skin and soft tissue infections medi.pptx
Skin and soft tissue infections medi.pptxSkin and soft tissue infections medi.pptx
Skin and soft tissue infections medi.pptx
parkviewinternending
Oral manifestations of bacterial infections
Oral manifestations of bacterial infectionsOral manifestations of bacterial infections
Oral manifestations of bacterial infections
Karishma Sirimulla
Bacterial infections
Bacterial infectionsBacterial infections
Bacterial infections
Abakash Deo
Surgery(surgical infections) 1-2
Surgery(surgical infections) 1-2Surgery(surgical infections) 1-2
Surgery(surgical infections) 1-2
Rashad Idrees
Microbiology lec5
Microbiology   lec5Microbiology   lec5
Microbiology lec5
MBBS IMS MSU
Skin and wound infection
Skin and wound infectionSkin and wound infection
Skin and wound infection
Saeed Bajafar
Skin disease ppt for nursing student
Skin disease ppt for nursing studentSkin disease ppt for nursing student
Skin disease ppt for nursing student
Patel Dharmendra
Skin and Soft Tissue Infections
Skin and Soft Tissue Infections Skin and Soft Tissue Infections
Skin and Soft Tissue Infections
Nireshan Naidoo
L1-SKIN-SOFT-TISSUE-MODEFIED.ppt
L1-SKIN-SOFT-TISSUE-MODEFIED.pptL1-SKIN-SOFT-TISSUE-MODEFIED.ppt
L1-SKIN-SOFT-TISSUE-MODEFIED.ppt
AISHWARYATD2
BACTERIAL120INFECTIONS.pptx
BACTERIAL120INFECTIONS.pptxBACTERIAL120INFECTIONS.pptx
BACTERIAL120INFECTIONS.pptx
GhazalaRizwan3
conj diseases main.pptx
conj diseases main.pptxconj diseases main.pptx
conj diseases main.pptx
Harmanjot Singh
Dr hussein, bacterial infec of the skin
Dr hussein, bacterial infec of the skinDr hussein, bacterial infec of the skin
Dr hussein, bacterial infec of the skin
MEEQAT HOSPITAL
Skin conditions of surgical Importance.pptx
Skin conditions of surgical Importance.pptxSkin conditions of surgical Importance.pptx
Skin conditions of surgical Importance.pptx
DakaneMaalim
Bacterial infection of the skin
Bacterial infection of the skin Bacterial infection of the skin
Bacterial infection of the skin
MEEQAT HOSPITAL
Staphylococcus aureus
Staphylococcus aureusStaphylococcus aureus
Staphylococcus aureus
IRFAN UL HAQ
Staphylococcus aureus
Staphylococcus aureusStaphylococcus aureus
Staphylococcus aureus
Athira B
Skin and soft tissue infections
Skin and soft tissue infectionsSkin and soft tissue infections
Skin and soft tissue infections
AMIT KUMAR
Microbiology 2009
Microbiology 2009Microbiology 2009
Microbiology 2009
kmwall
Skin and soft tissue infections for mbbs student.pptx
Skin and soft tissue infections for mbbs student.pptxSkin and soft tissue infections for mbbs student.pptx
Skin and soft tissue infections for mbbs student.pptx
sheetalbadsar19
Skin and soft tissue infections medi.pptx
Skin and soft tissue infections medi.pptxSkin and soft tissue infections medi.pptx
Skin and soft tissue infections medi.pptx
parkviewinternending
Oral manifestations of bacterial infections
Oral manifestations of bacterial infectionsOral manifestations of bacterial infections
Oral manifestations of bacterial infections
Karishma Sirimulla
Bacterial infections
Bacterial infectionsBacterial infections
Bacterial infections
Abakash Deo
Surgery(surgical infections) 1-2
Surgery(surgical infections) 1-2Surgery(surgical infections) 1-2
Surgery(surgical infections) 1-2
Rashad Idrees

Recently uploaded (20)

Non-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for NeurosurgeonsNon-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for Neurosurgeons
Dhaval Shukla
Renal Physiology - Regulation of GFR and RBF
Renal Physiology - Regulation of GFR and RBFRenal Physiology - Regulation of GFR and RBF
Renal Physiology - Regulation of GFR and RBF
MedicoseAcademics
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the FutureCreatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Steve Jennings
Eye assessment in polytrauma for undergraduates.pptx
Eye assessment in polytrauma for undergraduates.pptxEye assessment in polytrauma for undergraduates.pptx
Eye assessment in polytrauma for undergraduates.pptx
KafrELShiekh University
psychosomaticdisorder and it's physiotherapy management
psychosomaticdisorder and it's physiotherapy managementpsychosomaticdisorder and it's physiotherapy management
psychosomaticdisorder and it's physiotherapy management
Dr Shiksha Verma (PT)
Diabetic Ketoacidosis (DKA) & Its Management Protocol
Diabetic Ketoacidosis (DKA) & Its Management ProtocolDiabetic Ketoacidosis (DKA) & Its Management Protocol
Diabetic Ketoacidosis (DKA) & Its Management Protocol
Dr Anik Roy Chowdhury
Hemoblastosis lecture by pathological anatomy
Hemoblastosis lecture by pathological anatomyHemoblastosis lecture by pathological anatomy
Hemoblastosis lecture by pathological anatomy
26d78y5bwr
Optimization in Pharmaceutical Formulations: Concepts, Methods & Applications
Optimization in Pharmaceutical Formulations: Concepts, Methods & ApplicationsOptimization in Pharmaceutical Formulations: Concepts, Methods & Applications
Optimization in Pharmaceutical Formulations: Concepts, Methods & Applications
KHUSHAL CHAVAN
MLS 208 - UNIT 1- Lecture Notes - ETANDO AYUK - SANU - Secured.pdf
MLS 208 -  UNIT 1-  Lecture Notes - ETANDO AYUK - SANU - Secured.pdfMLS 208 -  UNIT 1-  Lecture Notes - ETANDO AYUK - SANU - Secured.pdf
MLS 208 - UNIT 1- Lecture Notes - ETANDO AYUK - SANU - Secured.pdf
Eswatini Medical Christian University - EMCU / Southern Nazarene University - SANU
legal Rights of individual, children and women.pptx
legal Rights of individual, children and women.pptxlegal Rights of individual, children and women.pptx
legal Rights of individual, children and women.pptx
Rishika Rawat
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
KHUSHAL CHAVAN
Presentaci坦 "Projecte Benestar". MWC 2025
Presentaci坦 "Projecte Benestar". MWC 2025Presentaci坦 "Projecte Benestar". MWC 2025
Presentaci坦 "Projecte Benestar". MWC 2025
Badalona Serveis Assistencials
4-PuroKalusugan 2025 DM 2025-0024 (1).pptx
4-PuroKalusugan 2025 DM 2025-0024 (1).pptx4-PuroKalusugan 2025 DM 2025-0024 (1).pptx
4-PuroKalusugan 2025 DM 2025-0024 (1).pptx
NashiedaLilangBuale
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptxphysiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
amralmohammady27
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...
ABHAY INSTITUTION
ISPE Baseline PEG Volumen 7 Risk-Based Manufacture Pharmaceutical Products 2n...
ISPE Baseline PEG Volumen 7 Risk-Based Manufacture Pharmaceutical Products 2n...ISPE Baseline PEG Volumen 7 Risk-Based Manufacture Pharmaceutical Products 2n...
ISPE Baseline PEG Volumen 7 Risk-Based Manufacture Pharmaceutical Products 2n...
alokksharma18
Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level CurriculumSudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Dr Ovels
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
PVI, PeerView Institute for Medical Education
Details Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & AyurvedaDetails Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & Ayurveda
RaviAnand201252
3. coronary circulation.pptx cardiovascular
3. coronary circulation.pptx cardiovascular3. coronary circulation.pptx cardiovascular
3. coronary circulation.pptx cardiovascular
Pooja Rani
Non-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for NeurosurgeonsNon-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for Neurosurgeons
Dhaval Shukla
Renal Physiology - Regulation of GFR and RBF
Renal Physiology - Regulation of GFR and RBFRenal Physiology - Regulation of GFR and RBF
Renal Physiology - Regulation of GFR and RBF
MedicoseAcademics
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the FutureCreatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Steve Jennings
Eye assessment in polytrauma for undergraduates.pptx
Eye assessment in polytrauma for undergraduates.pptxEye assessment in polytrauma for undergraduates.pptx
Eye assessment in polytrauma for undergraduates.pptx
KafrELShiekh University
psychosomaticdisorder and it's physiotherapy management
psychosomaticdisorder and it's physiotherapy managementpsychosomaticdisorder and it's physiotherapy management
psychosomaticdisorder and it's physiotherapy management
Dr Shiksha Verma (PT)
Diabetic Ketoacidosis (DKA) & Its Management Protocol
Diabetic Ketoacidosis (DKA) & Its Management ProtocolDiabetic Ketoacidosis (DKA) & Its Management Protocol
Diabetic Ketoacidosis (DKA) & Its Management Protocol
Dr Anik Roy Chowdhury
Hemoblastosis lecture by pathological anatomy
Hemoblastosis lecture by pathological anatomyHemoblastosis lecture by pathological anatomy
Hemoblastosis lecture by pathological anatomy
26d78y5bwr
Optimization in Pharmaceutical Formulations: Concepts, Methods & Applications
Optimization in Pharmaceutical Formulations: Concepts, Methods & ApplicationsOptimization in Pharmaceutical Formulations: Concepts, Methods & Applications
Optimization in Pharmaceutical Formulations: Concepts, Methods & Applications
KHUSHAL CHAVAN
legal Rights of individual, children and women.pptx
legal Rights of individual, children and women.pptxlegal Rights of individual, children and women.pptx
legal Rights of individual, children and women.pptx
Rishika Rawat
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...
KHUSHAL CHAVAN
4-PuroKalusugan 2025 DM 2025-0024 (1).pptx
4-PuroKalusugan 2025 DM 2025-0024 (1).pptx4-PuroKalusugan 2025 DM 2025-0024 (1).pptx
4-PuroKalusugan 2025 DM 2025-0024 (1).pptx
NashiedaLilangBuale
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptxphysiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
amralmohammady27
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...
ABHAY INSTITUTION
ISPE Baseline PEG Volumen 7 Risk-Based Manufacture Pharmaceutical Products 2n...
ISPE Baseline PEG Volumen 7 Risk-Based Manufacture Pharmaceutical Products 2n...ISPE Baseline PEG Volumen 7 Risk-Based Manufacture Pharmaceutical Products 2n...
ISPE Baseline PEG Volumen 7 Risk-Based Manufacture Pharmaceutical Products 2n...
alokksharma18
Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level CurriculumSudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Sudurpaschim logsewa aayog Medical Officer 8th Level Curriculum
Dr Ovels
Details Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & AyurvedaDetails Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & Ayurveda
RaviAnand201252
3. coronary circulation.pptx cardiovascular
3. coronary circulation.pptx cardiovascular3. coronary circulation.pptx cardiovascular
3. coronary circulation.pptx cardiovascular
Pooja Rani

Ofooni1_04_Staph.PPT

  • 1. Staphylococci Facultative, non-sporulating, non-motile, Gram positive cocci Cell Division 3 planes Daughter cells dont fully separate form clusters Greek nouns Staphyle a bunch of grapes Coccus grain or berry
  • 2. Disease Manifestations due to Staphylococcus aureus Skin and soft tissue infections Impetigo Osteomyelitis Endocarditis Septic phlebitis Catheter infections Toxic shock syndrome Septicemia
  • 3. Disease Manifestations due to Staphylococcus aureus Skin and soft tissue infections Impetigo Cellulite Osteomyelitis Pneumonia Endocarditis Septic phlebitis Catheter infections Surgical site infections Toxic shock syndrome Septicemia Septic arthritis
  • 4. Staphylococci 27 species Three Important Species Staphylococcus aureus Important human pathogen Staphylococcus epidermidis Normal skin flora, disease under special circumstances Staphylococcus saprophyticus UTIs in young females
  • 5. S. aureus - Epidemiology Reservoir Humans Asymptomatic Carriage Sites: Skin Colonization - Brief, Repeated Transmission -
  • 6. S. aureus - Epidemiology Reservoir Humans Asymptomatic Carriage Sites: Nares Rectum Perineum Pharynx Skin Colonization - Brief, Repeated Transmission - Person to Person
  • 7. S. aureus Carriage Rates Population Carriage Rate (%) General Population 25 Hemodialysis 75 Diabetic on insulin 50 Patients receiving 50 allergy shots Intravenous Drug Users 40
  • 8. Staphylococcal Infections - Risk Factors Skin Disease Increased colonization Trauma Expose binding sites Viral Respiratory Tract Infection (Influenza) Expose binding sites Decreased clearance Foreign Body Liver disease Neoplasia Diabetes Renal Failure Leukocyte & Immunoglobulin Defects Elevated Serum IgE Levels Narcotics Addiction Broad Spectrum Antibiotic Therapy In general Healthy people dont get serious Staph infections
  • 9. Patterns of Disease - S. aureus 1) Invasion with Tissue Destruction 2) Toxin Mediated
  • 10. Patterns of Disease - S. aureus 1) Invasion with Tissue Destruction 2) Toxin Mediated Toxic Shock Syndrome Scalded Skin Syndrome Staphylococcal Food Poisoning
  • 11. Anterior Nares Skin Trauma Localized Colonization Infection Bacteremia Metastatic Foci Lungs Endocarditis Liver/Spleen CNS Kidneys
  • 14. Folliculitis Starts as infection of hair follicle Folliculitis
  • 17. A 22-month-old boy with a staphylococcal folliculitis on the buttocks. The lesions have been excoriated. Diaper occlusion may have been related to onset of the rash.
  • 18. Furuncle Often starts as infection of hair follicle Folliculitis Firm, tender red nodule Painful Fluctuant with time Drain spontaneously
  • 27. Carbuncle Larger than furuncle Extends into subcutaneous fat Interconnected Firm, inelastic skin
  • 33. Impetigo The most common skin infection in children. Causative agent is carried in the nasal area. Bacteria invade the superficial skin.
  • 34. Impetigo Superficial infection of skin Usually S. aureus Streptococcus pyogenes Children Hot Weather Minor Trauma Initially vesicles
  • 35. Impetigo Later: Crusted with yellow dark brown material
  • 39. Interventions Good general hygiene Wash gently with soap and water Topical antibiotic therapy Wash hands Systemic antibiotics only if severe and does not respond to topical. (keflex po)
  • 41. Erysipelas Strep pyogenes or S. aureus Sharp, raised borders
  • 44. Cellulitis A full-thickness skin infection involving dermis and underlying connective tissue. Any part of the body can be affected. Cellulitis around the eyes is usually an extension of a sinus infection or otitis media.
  • 45. Cellulitis Acute, spreading Infection Prior trauma to skin Warm and erethematous
  • 46. Assessment History and physical exam WBC count Blood culture Culturing organism from lesion aspiration. CT scan with peri-orbital cellulitis
  • 47. Clinical Manifestations Characteristic reddened or lilac- colored, swollen skin that pits when pressed with finger. Borders are indistinct. Warm to touch. Superficial blistering.
  • 56. Periorbital swelling and Fever after dental abscess
  • 60. Imaging Air, edema and collection in orbital cavity More than 遜 of orbit is anterior to orbital cavity (proptosis) Bilateral Ethmoid sinusitis
  • 62. Bilateral Maxillary Bilateral Ethmoidal sinusitis Soft tissue swelling , edema & collection intraorbital cavity Congested Nasal conchea
  • 70. Interventions Hospitalization if large area involved or facial cellulitis. IV antibiotics. Pain management. Warm moist packs to area if ordered. Assess for spread If peri-orbital test for ocular movement and vision acuity
  • 73. sty
  • 75. Cortex Abscess Periosteal reactive bone Bone resorption: osteoclast Organisation: fibrosis Trabeculae New reactive bone: osteoblasts Pyogenic osteomyelitis -pathogenesis
  • 76. Expansion of abscess Periosteal elevation Shearing of arteries Subperiosteal abscess Reactive bone Ischemia = osteonecrosis (sequestrum) Pyogenic osteomyelitis -pathogenesis
  • 77. Pus in joint Extension into soft tissue Draining sinus Skin Cortical necrosis = sequestrum Reactive bone surround sequestrum: involucrum Continuous resorption Continuous new bone and fibrosis of marrow sequestrum Pyogenic osteomyelitis -pathogenesis
  • 93. Patterns of Disease - S. aureus 1) Invasion with Tissue Destruction 2) Toxin Mediated Toxic Shock Syndrome Scalded Skin Syndrome Staphylococcal Food Poisoning
  • 94. TOXIC SHOCK SYNDROME Acute Febrile Illness Subsequent Development of Hypotension and Shock. Noted association with S. aureus phage group I Named the illness "Toxic Shock Syndrome
  • 95. TOXIC SHOCK SYNDROME 1990 - More than 3,300 cases have been reported 95% in women 90% occurred during menstruation in women who were using tampons 1989 - 61 cases of TSS reported
  • 96. Toxic Shock Syndrome - Epidemiology 1. Menstrual Colonization of the Vagina and Cervix with TSST-1 producing strains of S. aureus Tampon Associated Risk proportional to the absorbancy of Tampon Not tampon associated
  • 97. Toxic Shock Syndrome - Epidemiology 2. Non-menstrual Post-surgical Influenza associated Contraceptive device associated Diaphragm Sponge Postpartum
  • 98. Pyrogenic Toxin Family of Proteins secreted by S. aureus Strep pyogenes Include TSST-1 Staphylococcal Enterotoxins A, B,C Pyrogenic Exotoxin A & B Streptococcal Scarlet Fever Toxins A, B,C
  • 99. Toxic Shock Syndrome - Clinical Manifestations 1. High Fever (>39.9oC) 2. Scarlatiniform Eruption 3. Hypotension and Shock 4. Desquamation during convalescence
  • 100. Staphylococcal toxic shock syndrome Toxic shock syndrome (TSS) Toxic shock syndrome toxin (TSST-1) Super antigen Tampon or infected wound, TSST- 1 enters blood stream and cause fever, rash, exfoliation of skin and shock (death rate 3%)
  • 101. Manifestations of Specific Organ Involvement Mucous Membranes: hyperemia Gastrointestinal Tract: vomiting and diarrhea Muscle: severe myalgias Central Nervous System: disorientation Kidney: azotemia, pyuria urinary tract infection Liver: elevation of serum bilirubin and SGOT Blood: Thrombocytopenia
  • 102. Toxic Shock Syndrome - Diagnosis Isolation of toxin producing S. aureus from a patient with a compatible clinical illness.
  • 103. Toxic Shock Syndrome - Treatment 1) Treatment of Hypotension and Shock Vigorous Fluid Replacement 2) Attention to the Site of S. aureus Colonization Removal of Tampons Drainage of Staphylococcal Abscess 3) Anti-Staphylococcal Antibiotic Therapy
  • 104. STAPHYLOCOCCAL SCALDED SKIN SYNDROME A Disease of Infants Localized Infection with Diffuse Skin Rash S. aureus (Phage group II) recovered from: Nose Pustules Eye Umbilicus Exfoliative Toxin Two Serologically and Biologically Distinct Proteins Exfoliatin A Exfoliatin B Inter-Epithelial Splitting of Stratum Granulosum Layer
  • 105. Staphylococcal Scalded Skin Syndrome - Clinical Features Starts Abruptly Perioral erythema Sunburn like, tender rash spreads over entire body Bullae Appear Rapidly Nikolsky sign Flaccid bullae slough off Denuded areas
  • 106. Staphylococcal Scalded Skin Syndrome - Clinical Features Exfoliated Areas Eventually Dry Flaky desquamation lasting 3-5 days Within 10 days After Onset Complete Recovery New epidermis has replaced the denuded areas
  • 109. Staphylococcal scalded skin syndrom (SSSS) Exfoliative toxin (epidermolytic toxin) Bullous exfoliative dermatitis
  • 110. Staphylococcal Food Poisoning 20% of Outbreaks of Acute Food Poisoning Toxigenic Strain of S. aureus growing in contaminated food Produces Enterotoxin B (Heat Stable) Person to Person Transmission Responsible organism usually isolated from person involved meal preparation
  • 111. Staphylococcal Food Poisoning Commonly implicated foods Custard filled bakery good Canned food Potato salad Ice cream Food appears normal in appearance, odor and taste
  • 112. Staphylococcal Food Poisoning - Clinical Features Incubation period 2-6 hours Enterotoxin stimulates intestinal peristalsis and CNS Abrupt onset: Salivation Nausea and vomiting Abdominal cramps Watery diarrhea Afebrile Self limited, symptoms disappear in 8 hours
  • 114. S. aureus Evolution of Drug Resistance in S. aureus Methicillin [1970s] Methicillin- resistant S. aureus (MRSA) S. aureus Penicillin [1950s] Penicillin-resistant Vancomycin-resistant enterococci (VRE) Vancomycin [1990s] [1997] Vancomycin intermediate- resistant S. aureus (VISA) [ 2002 ] Vancomycin- resistant S. aureus
  • 115. Bone5: 7%13% Vancomycin Penetration Sternal Bone1: 57% Heart Valve4: 12% CNS: <10% Fat4: 14% Muscle4: 9% Epithelial lining fluid3: 18% Lung tissue2: 17%24% 1. Massias L et al. Antimicrob Agents Chemother. 1992;36:2539-2541; 2. Cruciani M et al. J Antimicrob Chemother. 1996;38:865-869. 3. Lamer C et al. Antimicrob Agents Chemother. 1993;37:281-286;
  • 116. MRSA in Europe. In England and Wales, from January to December 1999 methicillin resistance was 37% of the S.aureus reports. Except Scandinavia and Netherlands most countries have high rates of MRSA.
  • 117. 0 10 20 30 40 50 60 1 9 7 5 8 7 8 8 8 9 9 0 9 1 9 2 9 3 9 4 9 5 9 6 9 7 9 8 9 9 2 0 0 0 2 0 0 2 Resistant isolates (%) CDC. MMWR. 1997;46:624-628, 635. (1975 data); Lowy FD. N Engl J Med. 1998;339:520-532. Progression of Methicillin Resistant S aureus United States 13% 居件縁 居居鰹
  • 118. Staphylococcus aureus (N0=224) CD ER LZD PG TS RP OX CIP C KF AK T VA QD GM FU R 53 (24) 80 (36) 4 (2) 215 (96) 92 (41) 20 (9) 78 (35) 72 (32) 5 (2) 71 (32) 70 (31) 102 (45) 0 (0) 0 (0) 72 (32) 8 (4) S 170 (76) 130 (58) 220 (98) 9 (4) 131 (58) 203 (90) 146 (65) 148 (66) 218 (97) 151 (67) 150 (68) 122 (55) 224 (100) 224 (100) 152 (68) 216 (96) IR 1 (0.5) 14 (6) 0 (0) 0 (0) 1 (.5) 1 (.5) 0 (0) 4 (2) 1 (.5) 2 (1) 3 (1) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) CD=Clindamycin, ER=erythromycin, LZD=linezolid, PG=PenicillinG, TS=Co-trimoxazol, RP=Rifampin, OX=Oxacillin, CIP=Ciprofloxacin, C=Chloramphenicol, KF=Cephalothin, AK=Amikacin, T=Tetracycline, VA=Vancomycin, QD=Quinupristin-dalfopristin, GM=Gentamycin, FU=Fusidic acid
  • 119. Reservoir for the Spread of Antibiotic Resistant Pathogens clinical infections colonized (asymptomatic)
  • 120. Standard Precautions for Health Care workers include: Hand hygiene / handwashing- before and after patient contact and after touching contaminated items Gloving - when touching blood, body fluids, secretions, excretions,and contaminated items Masking if aerosol of infectious material expected Gowning Appropriate handling of laundry
  • 121. Most common mode of transmission of pathogens is via hands! So Why All the Fuss About Hand Hygiene?
  • 122. The Inanimate Environment Can Facilitate Transmission ~ Contaminated surfaces increase cross-transmission ~ Abstract: The Risk of Hand and Glove Contamination after Contact with a VRE (+) Patient Environment. Hayden M, ICAAC, 2001, Chicago, IL. X represents VRE culture positive sites
  • 123. Staphylococcus epidermidis Normal Flora Virtually all humans carry S. epidermidis on the skin and in and around body orifices Hospital Acquired Infection Contamination by S. epidermidis carried by the patient most important event in infections associated with foreign bodies
  • 124. Staphylococcus epidermidis opportunistic infection - less common than S.aureus nosomial infections - shunts, catheters artificial heart valves/joints
  • 125. S. epidermidis - Patterns of Infection Nosocomial Bacteremia -most common cause Endocarditis A. Native Valve Uncommon- 5% of cases B. Prosthetic Valve Single most common cause (40% of cases) Probably caused by inoculation at the time of surgery Indolent course
  • 126. S. epidermidis - Patterns of Infection Intravenous Catheters -Single most common cause (50-75% of cases) Cerebrospinal Fluid Shunts Peritoneal Dialysis Catheter Vascular Grafts Prosthetic Joints
  • 127. S. epidermidis Infection - Treatment 1. Antimicrobial Therapy Usually resistant to multiple antibiotics Beta lactams Erythromycin, Clindamycin, Tetracycline Require therapy with Vancomycin 2. Removal of Foreign Body
  • 128. Staphylococcus saprophyticus Colonizes the genitourinary mucosa of some young women Causes both upper and lower urinary tract disease 95% of cases are in females 16-35 years old Responsible for 20% of the UTI's in this age group Second only to E. coli Pathogen of young, sexually active females 70% sexual intercourse within 24 hours preceding onset of symptoms